The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance

被引:347
作者
Rinella, ME
Green, RM
机构
[1] Northwestern Univ, Feinberg Sch Med, Div Hepatol, Chicago, IL 60611 USA
[2] Div Gastroenterol & Hepatol, Chicago, IL 60611 USA
[3] Lakeside Vet Adm Med Ctr, Chicago, IL 60611 USA
关键词
alanine transaminase; steatohepatitis; non-alcoholic steatohepatitis; glucose; insulin resistance; quantitative insulin sensitivity check index; liver;
D O I
10.1016/j.jhep.2003.09.020
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Aims: Non-alcoholic steatohepatitis is an important disease whose pathophysiology remains incompletely understood, although in humans a strong association with insulin resistance exists. Mice fed a methionine-choline deficient (MCD) diet develop steatohepatitis, however the influence of insulin in this model is unknown. Methods: Male FVB/NJ mice were fed the MCD, MCD control or chow diet for 10 or 28 days. Fasting glucose, ALT, triglyceride and insulin was measured. Glucose tolerance tests (GTT) and insulin tolerance tests (ITT) were performed followed by quantitative insulin sensitivity check index (QUICKI) determination. Results: ALT levels were significantly higher in the MCD group. Fasting glucose was 81 +/- 5 mg/dl in MCD diet fed mice, compared to MCD controls (196 +/- 46 mg/dl) and chow (199 +/- 15 mg/dl) (P < 0.0001). During GTT and ITT, the effect of glucose administration on blood glucose was dampened, and the insulin effect more pronounced in the MCD group (P = 0.026 and P < 0.001). QUICKI in MCD fed mice was significantly higher than in the chow fed mice. Conclusions: GTT, ITT and QUICKI confirmed the absence of insulin resistance in the MCD fed mice. This model causes fibrosing steatohepatitis and may help delineate the non-insulin resistant mechanisms involved in human steatohepatitis. (C) 2003 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:47 / 51
页数:5
相关论文
共 31 条
[1]   Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis [J].
Angulo, P ;
Keach, JC ;
Batts, KP ;
Lindor, KD .
HEPATOLOGY, 1999, 30 (06) :1356-1362
[2]   Non-alcoholic fatty liver disease [J].
Angulo, P ;
Lindor, KD .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 :S186-S190
[3]   Nonalcoholic steatohepatitis: Definition and pathology [J].
Brunt, EM .
SEMINARS IN LIVER DISEASE, 2001, 21 (01) :3-16
[4]   Expanding the natural history from cryptogenic cirrhosis to of nonalcoholic steatohepatitis: Hepatocellular carcinoma [J].
Bugianesi, E ;
Leone, N ;
Vanni, E ;
Marchesini, G ;
Brunello, F ;
Carucci, P ;
Musso, A ;
De Paolis, P ;
Capussotti, L ;
Salizzoni, M ;
Rizzetto, M .
GASTROENTEROLOGY, 2002, 123 (01) :134-140
[5]   Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease [J].
Caldwell, SH ;
Oelsner, DH ;
Iezzoni, JC ;
Hespenheide, EE ;
Battle, EH ;
Driscoll, CJ .
HEPATOLOGY, 1999, 29 (03) :664-669
[6]   Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats [J].
Cefalu, WT ;
Wang, ZQ ;
Zhang, XH ;
Baldor, LC ;
Russell, JC .
JOURNAL OF NUTRITION, 2002, 132 (06) :1107-1114
[7]   NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome [J].
Chitturi, S ;
Abeygunasekera, S ;
Farrell, GC ;
Holmes-Walker, J ;
Hui, JM ;
Fung, C ;
Karim, R ;
Lin, R ;
Samarasinghe, D ;
Liddle, C ;
Weltman, M ;
George, J .
HEPATOLOGY, 2002, 35 (02) :373-379
[8]   Disruption of Sur2-containing KATP channels enhances insulin-stimulated glucose uptake in skeletal muscle [J].
Chutkow, WA ;
Samuel, V ;
Hansen, PA ;
Pu, JL ;
Valdivia, CR ;
Makielski, JC ;
Burant, CF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (20) :11760-11764
[9]   Nonalcoholic Steatosis and Steatohepatitis. I. Molecular mechanism for polyunsaturated fatty acid regulation of gene transcription [J].
Clarke, SD .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2001, 281 (04) :G865-G869
[10]   The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome [J].
Diamanti-Kandarakis, E ;
Mitrakou, A ;
Raptis, S ;
Tolis, G ;
Duleba, AJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (08) :2699-2705